Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk Hertwig

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Pharmacological Research|January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacyLaura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
Cancer Cell|March 14, 2018
Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory AxisTanmoy Mondal, Prasanna Kumar Juvvuna, Agnete Kirkeby, et al.
Cancer Letters|May 4, 2025
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progressionJelena Milosevic, Susanne Fransson, Johanna Svensson, et al.
Nature Communications|November 24, 2021
Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisionsKarin Schmelz, Joern Toedling, Matt Huska, et al.
Nature Communications|July 4, 2023
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCNSteffen Fuchs, Clara Danßmann, Filippos Klironomos, et al.
Nature Communications|November 17, 2020
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastomaKonstantin Helmsauer, Maria E Valieva, Salaheddine Ali, et al.
Cell|January 8, 2019
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsRon D Jachimowicz, Filippo Beleggia, Jörg Isensee, et al.
Molecular Cancer|June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cellsMareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Nature Genetics|February 29, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Nature Genetics|December 18, 2019
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pharmacological Research|January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacyLaura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
Cancer Cell|March 14, 2018
Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory AxisTanmoy Mondal, Prasanna Kumar Juvvuna, Agnete Kirkeby, et al.
Cancer Letters|May 4, 2025
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progressionJelena Milosevic, Susanne Fransson, Johanna Svensson, et al.
Nature Communications|November 24, 2021
Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisionsKarin Schmelz, Joern Toedling, Matt Huska, et al.
Nature Communications|July 4, 2023
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCNSteffen Fuchs, Clara Danßmann, Filippos Klironomos, et al.
Nature Communications|November 17, 2020
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastomaKonstantin Helmsauer, Maria E Valieva, Salaheddine Ali, et al.
Cell|January 8, 2019
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsRon D Jachimowicz, Filippo Beleggia, Jörg Isensee, et al.
Molecular Cancer|June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cellsMareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Nature Genetics|February 29, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Nature Genetics|December 18, 2019
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Pageof 4